Literature DB >> 8607114

Immunoassay of murine t-PA, u-PA and PAI-1 using monoclonal antibodies raised in gene-inactivated mice.

P J Declerck1, M Verstreken, D Collen.   

Abstract

Three enzyme-linked immunosorbent assays for the quantitation of murine tissue-type plasminogen activator (t-PA), urokinase-type plasminogen activator (u-PA) and plasminogen activator inhibitor 1 (PAI-1), were developed using monoclonal antibodies raised against the autologous proteins in gene-inactivated mice. Dose-response was linear for t-PA and PAI-1 between 5 and 0.1 ng/ml and for u-PA between 50 and 1 ng/ml, with intra-assay, inter-assay and inter-dilution coefficients of variation of 6 to 14%. Assay recoveries of proteins (5 to 100 ng/ml) added to plasma were 73 to 95% for t-PA and PAI-1. Linear correlations (r = 0.65, r = 0.91 and r = 0.92, for t-PA, u-PA and PAI-1 respectively) were found between antigen and activity in plasma, urine and tissue extracts. Levels of t-PA and PAI-1 antigen in murine plasma were 2.5 +/- 1.0 ng/ml (mean +/- SD, n=9) and 1.9 +/- 0.6 ng/ml (mean +/- SD, n = 8), respectively, in wild-type mice and undetectable in gene-inactivated mice. Bradykinin injection in mice provoked a 12-fold increase (p < 0.0002) of t-PA and endotoxin injection an 80-fold increase (p < 0.005) of PAI-1 levels. u-PA antigen levels in urine from wild-type mice ranged between 0.2 and 8.2 micrograms/ml (1.8 +/- 1.9 micrograms/ml, mean +/- SD, n = 17) and were undetectable in gene-inactivated mice. Thus, these assays may be useful for studies on the role of these proteins in tissue remodeling, atherosclerosis, embryogenesis, etc., in established mouse models. Gene-inactivated mice may constitute a general approach for the generation of monoclonal antibodies against the deficient translation products and for the development of specific immunoassays for murine proteins.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8607114

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Urothelial function reconsidered: a role in urinary protein secretion.

Authors:  F M Deng; M Ding; R M Lavker; T T Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2001-01-02       Impact factor: 11.205

2.  Activated human protein C prevents thrombin-induced thromboembolism in mice. Evidence that activated protein c reduces intravascular fibrin accumulation through the inhibition of additional thrombin generation.

Authors:  P Gresele; S Momi; M Berrettini; G G Nenci; H P Schwarz; N Semeraro; M Colucci
Journal:  J Clin Invest       Date:  1998-02-01       Impact factor: 14.808

3.  Plasminogen activator inhibitor-1 impairs plasminogen activation-mediated vascular smooth muscle cell apoptosis.

Authors:  Patrick Rossignol; Eduardo Anglès-Cano; Henri Roger Lijnen
Journal:  Thromb Haemost       Date:  2006-11       Impact factor: 5.249

4.  Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia.

Authors:  C Lupu; O Herlea; H Tang; R H Lijnen; F Lupu
Journal:  J Thromb Haemost       Date:  2013-01       Impact factor: 5.824

5.  C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet.

Authors:  M Poggi; D Bastelica; P Gual; M A Iglesias; T Gremeaux; C Knauf; F Peiretti; M Verdier; I Juhan-Vague; J F Tanti; R Burcelin; M C Alessi
Journal:  Diabetologia       Date:  2007-04-11       Impact factor: 10.122

6.  A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.

Authors:  Emma East; David Baker; Gareth Pryce; H Roger Lijnen; M Louise Cuzner; Djordje Gverić
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

7.  Tissue plasminogen activator prevents white matter damage following stroke.

Authors:  Fernando Correa; Maxime Gauberti; Jérôme Parcq; Richard Macrez; Yannick Hommet; Pauline Obiang; Miriam Hernangómez; Axel Montagne; Géraldine Liot; Carmen Guaza; Eric Maubert; Carine Ali; Denis Vivien; Fabian Docagne
Journal:  J Exp Med       Date:  2011-05-16       Impact factor: 14.307

8.  Inhibitory Monoclonal Antibodies against Mouse Proteases Raised in Gene-Deficient Mice Block Proteolytic Functions in vivo.

Authors:  Ida K Lund; Morten G Rasch; Signe Ingvarsen; Jesper Pass; Daniel H Madsen; Lars H Engelholm; Niels Behrendt; Gunilla Høyer-Hansen
Journal:  Front Pharmacol       Date:  2012-06-28       Impact factor: 5.810

9.  Transgenic overexpression of a stable Plasminogen Activator Inhibitor-1 variant.

Authors:  Abigail T Fahim; He Wang; Jining Feng; David Ginsburg
Journal:  Thromb Res       Date:  2008-09-05       Impact factor: 3.944

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.